Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma (melasma)
This study is not yet open for participant recruitment.
Study NCT00717652   Information provided by L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
First Received: July 15, 2008   Last Updated: July 16, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melasma
Additional conditions recognized in this trial
Melanosis
More general conditions related to this trial
Hyperpigmentation
Pigmentation Disorders
Skin Diseases
Interventions listed in this trial
arbutin, tretinoin, triamcinolone
Triluma
Additional drug interventions recognized in this trial
Tretinoin
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antineoplastic Agents
Dermatologic Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Keratolytic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services